Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · IEX Real-Time Price · USD
6.00
-0.12 (-1.96%)
May 20, 2022 4:30 PM EDT - Market closed

Balance Sheet (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302019-12-31
Cash & Equivalents
88.59291.06122.17136.95-39.05-16.84
Short-Term Investments
179.26000-0-0
Cash & Cash Equivalents
267.85291.06122.17136.95039.05016.84
Cash Growth
-645.46%-713.03%----
Other Current Assets
4.867.641.350.69-0.9-0.59
Total Current Assets
272.71298.7123.53137.64-39.95-17.44
Property, Plant & Equipment
38.616.265.95.09-3.04-0.8
Other Long-Term Assets
5.380.872.970.79-0.54-0
Total Long-Term Assets
43.997.138.875.88-3.58-0.8
Total Assets
316.7305.83132.4143.51-43.53-18.24
Accounts Payable
2.930.712.281.88-1.6-0.71
Current Debt
7.97000-0-0
Other Current Liabilities
4.526.014.882.66-1.76-1.21
Total Current Liabilities
15.436.727.164.54-3.36-1.92
Long-Term Debt
23.89000-0-0
Other Long-Term Liabilities
00.40.340.5---0.02
Total Long-Term Liabilities
23.890.40.340.5-0-0.02
Total Liabilities
39.317.127.55.04-3.36-1.94
Total Debt
31.86000-0-0
Common Stock
394.27392.392.631.7801.0200.47
Retained Earnings
-115.34-93.67-75.22-60.79--42.51--15.99
Comprehensive Income
-1.54000-0-0
Shareholders' Equity
277.39298.72-72.59-59.01--41.49--15.52
Total Liabilities and Equity
316.7305.83-65.09-53.980-38.130-13.58
Net Cash / Debt
236291.06122.17136.95039.05016.84
Net Cash / Debt Growth
-645.46%-713.03%----
Net Cash Per Share
7.5546.4482.82106.10-35.33-2.49
Working Capital
257.29291.98116.37133.1-36.59-15.52
Book Value Per Share
8.8847.66-49.21-45.72--37.54--2.30
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).